Last update 31 May 2025

Recombinant Factor VIII(Pfizer Inc.)

Overview

Basic Info

Drug Type
Recombinant coagulation factor
Synonyms-
Target
F10
Action
stimulants
Mechanism
F10 stimulants(Coagulation factor X stimulants), Coagulation factor VIII replacements
Therapeutic Areas
Congenital DisordersHemic and Lymphatic DiseasesOther Diseases
Active Indication-
Inactive Indication
Hemophilia A
Originator Organization
Pfizer Inc.Pfizer Inc.
Active Organization-
Inactive Organization
Wyeth ABPfizer Inc.Pfizer Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Recombinant Factor VIII(Pfizer Inc.)
EUCTR2005-005103-41-DK
/ Not yet recruitingPhase 2IIT
Clot formation and clot stability in severe haemophilia A - effect of recombinant factor VIII and tranexamic acid.
NCT00141843
/ CompletedPhase 3
A Randomized Two-Way Blinded Crossover-Design Study to Establish the Bioequivalence of B-Domain Deleted Recombinant Factor VIII (BDDrFVIII,Refacto AF) With a Full Length Recombinant Factor VIII Preparation (FLrFVIII,Advate), Followed by an Open-Label Trial of the Safety and Efficacy of ReFacto AF in Previously Treated Patients With Hemophilia A.
100 Clinical Results associated with Recombinant Factor VIII(Pfizer Inc.)
Login to view more data
100 Translational Medicine associated with Recombinant Factor VIII(Pfizer Inc.)
Login to view more data
100 Patents (Medical) associated with Recombinant Factor VIII(Pfizer Inc.)
Login to view more data
100 Deals associated with Recombinant Factor VIII(Pfizer Inc.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hemophilia APhase 3
United States
Wyeth AB
01 Jul 2005
Hemophilia APhase 3
Australia
Wyeth AB
01 Jul 2005
Hemophilia APhase 3
Belgium
Wyeth AB
01 Jul 2005
Hemophilia APhase 3
Finland
Wyeth AB
01 Jul 2005
Hemophilia APhase 3
France
Wyeth AB
01 Jul 2005
Hemophilia APhase 3
Germany
Wyeth AB
01 Jul 2005
Hemophilia APhase 3
Hungary
Wyeth AB
01 Jul 2005
Hemophilia APhase 3
Italy
Wyeth AB
01 Jul 2005
Hemophilia APhase 3
Netherlands
Wyeth AB
01 Jul 2005
Hemophilia APhase 3
New Zealand
Wyeth AB
01 Jul 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free